Indian pharma industry makes its presence felt at CPhI Worldwide 2014

With the participation of 230 companies in the event held in Paris, India’s positioning of a responsible healthcare resonates amongst global stakeholders

cphl-paris-india-reps

The India Pavilion was inaugurated by Mr Rajeev Kher, commerce secretary, Government of India along with Mr Arun Kumar Singh, ambassador of India to France, Dr G N Singh, drugs controller general of India

On the back of an aggressive branding showcase managed by India Brand Equity Foundation (IBEF), the Brand India Pharma campaign made its presence felt on the first day of CPhI Worldwide 2014. With a 360-degree strategy, IBEF has been leading the Brand India Pharma campaign since its launch in March, 2012 under the aegis of the Department of Commerce. This is the third consecutive presence of the campaign at CPhI Worldwide, one of the most prestigious pharmaceutical events across the globe. Around 230 Indian companies are participating at CPhI Worldwide this year. CPhI Worldwide is the largest pharmaceutical trade exhibition and is being held from October 7-9, 2014 in Paris.

Present at the India Pavilion were Mr Rajeev Kher, commerce secretary, Government of India along with Mr Arun Kumar Singh, ambassador of India to France; Dr G N Singh, drugs controller general of India; Mr B P Pandey, additional secretary and financial advisor, Department of Commerce, Government of India; Mr Sudhanshu Pandey, joint secretary, Department of Commerce, Government of India; Ms Aparna Dutt Sharma, CEO, IBEF; Mr Amruth Rao, Licensing Authority, DCA, Telangana; Mr H G Koshia, commissioner, Food and Drug Control Administration, Gujarat and Dr P V Appaji, director general, Pharmaceuticals Export Promotion Council of India (Pharmexcil) in the presence of major Indian pharmaceutical companies in Hall 6 at the Paris Nord Villepinte, France.

"The Indian pharmaceutical industry stands with the full support of the Government of India. For instance, our increasing participation at global exhibitions like CPhI Worldwide demonstrates the commitment to the sector," said Mr Rajeev Kher.

"There are around five Indian companies in the list of top 20 global generic companies. Indian companies are looking at making healthcare accessible and affordable for the global population," said Mr Sudhanshu Pandey.

"This is one of the most expansive showcases from the Indian pharmaceutical industry at CPhI Worldwide. We are confident that the focused activities will deliver a marked improvement in the awareness levels of the global industry," said Ms Aparna Dutt Sharma.

 

Previous 1 Next

Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box

GST

GST: Boon or Bane for Healthcare?

Send this article by email

X